Failure of cefepime therapy in treatment of Klebsiella pneumoniae bacteremia

Journal of Clinical Microbiology

Volumn 43, Issue 9, 2005, Pages 4891-4894

  Song, Wonkeun ^a   Moland, Ellen S ^a   Hanson, Nancy D ^a   Lewis, James S ^b   Jorgensen, James H ^b   Thomson, Kenneth S ^a  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AZTREONAM; BETA LACTAMASE; CEFEPIME; CEFOTAXIME; CEFOTETAN; CEFOXITIN; CEFPODOXIME; CEFTAZIDIME; CHLORAMPHENICOL; CIPROFLOXACIN; CLAVULANIC ACID; CLOXACILLIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; KANAMYCIN;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERIUM ISOLATE; BLOOD CULTURE; CASE REPORT; ENZYME ASSAY; HUMAN; KLEBSIELLA PNEUMONIAE; MALE; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; TREATMENT FAILURE;

ANTI-BACTERIAL AGENTS; BACTEREMIA; BACTERIAL PROTEINS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CEPHALOSPORINS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; TREATMENT FAILURE;

KLEBSIELLA PNEUMONIAE;

EID: 24744459648     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.43.9.4891-4894.2005     Document Type: Article

References (22)

1. Alvarez, M., J. H. Tran, N. Chow, and G. A. Jacoby. 2004. Epidemiology of conjugative plasmid-mediated AmpC beta-lactamases in the United States. Antimicrob. Agents Chemother. 48:533-537.
2. Bauernfeind, A., H. Grimm, and S. Schweighart. 1990. A new plasmidic cefotaximase in a clinical isolate of Escherichia coli. Infection 18:294-298.
3. 2a. Black, J. A., E. Smith Moland, and K. S. Thomson. 2005. AmpC disk test for detection of plasmid-mediated AmpC β-lactamases in Enterobacteriaceae lacking chromosomal AmpC β-lactamases. J. Clin. Microbiol. 43:3110-3113.
4. Brun-Buisson, C., P. Legrand, A. Philippen, F. Montravers, M. Ansquer, and J. Duval. 1987. Transferable enzymatic resistance to third-generation cephalosporins during nosocomial outbreak of multiresistant Klebsiella pneumoniae. Lancet ii:302-306.
5. Carpenter, J. L. 1990. Klebsiella pulmonary infections: occurrence at one medical center and review. Rev. Infect. Dis. 12:672-682.
6. Hanson, N. D. 2003. AmpC beta-lactamases: what do we need to know for the future? J. Antimicrob. Chemother. 52:2-4.
7. Hanson, N. D., K. S. Thomson, E. S. Moland, C. C. Sanders, G. Berthold, and R. Penn. 1999. Molecular characterization of a multiply resistant Klebsiella pneumonias encoding ESBLs and a plasmid-mediated AmpC. J. Antimicrob. Chemother. 44:377-380.
8. Jacoby, G. A., and P. Han. 1996. Detection of extended-spectrum β-lactamases in clinical isolates of Klebsiella pneumonias and Escherichia coli. J. Clin. Microbiol. 34:908-911.
9. Korvick, J. A., C. S. Bryan, B. Farber, T. R. Beam, Jr., L. Schenfeld, R. R. Muder, D. Weinbaum, R. Lumish, D. N. Gerding, and M. M. Wagener. 1992. Prospective observational study of Klebsiella bacteremia in 230 patients: outcome for antibiotic combinations versus monotherapy. Antimicrob. Agents Chemother. 36:2639-2644.
10. Miranda, G., C. Kelly, F. Solorzano, B. Leanos, R. Coria, and J. E. Patterson. 1996. Use of pulsed-field gel electrophoresis typing to study an outbreak of infection due to Serratia marcescens in a neonatal intensive care unit. J. Clin. Microbiol. 34:3138-3141.
11. Moland, E. S., J. A. Black, J. Ourada, M. D. Reisbig, N. D. Hanson, and K. S. Thomson. 2002. Occurrence of newer beta-lactamases in Klebsiella pneumoniae isolates from 24 U.S. hospitals. Antimicrob. Agents Chemother. 46:3837-3842.
12. National Committee for Clinical Laboratory Standards. 2003. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 5th ed. Approved standard M7-A6. National Committee for Clinical Laboratory Standards, Wayne, Pa.
13. National Committee for Clinical Laboratory Standards. 2003. Performance standards for antimicrobial disk susceptibility testing, 8th informational supplement. Approved standard M2-A7. National Committee for Clinical Laboratory Standards, Wayne, PA.
14. National Committee for Clinical Laboratory Standards. 2004. Performance standards for antimicrobial susceptibility testing, 11th informational supplement M100-S14. National Committee for Clinical Laboratory Standards, Wayne, PA.
15. Nüesch-Inderbinen, M. T., H. Hächler, and F. H. Kayser. 1996. Detection of genes coding for extended-spectrum SHV beta-lactamases in clinical isolates by a molecular genetic method, and comparison with the E test. Eur. J. Clin. Microbiol. Infect. Dis. 15:398-402.
16. Perez-Perez, F. J., and N. D. Hanson. 2002. Detection of plasmid-mediated AmpC beta-lactamase genes in clinical isolates by using multiplex PCR. J. Clin. Microbiol. 40:2153-2162.
17. Philippon, A., G. Arlet, and G. A. Jacoby. 2002. Plasmid-determined AmpC-type beta-lactamases. Antimicrob. Agents Chemother. 46:1-11.
18. Sambrook, J., E. F. Fritsch, and T. Maniatus. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N. Y.
19. Sanders, C. C., W. E. Sanders, Jr., and E. S. Moland. 1986. Characterization of β-lactamases in situ on polyacrylamide gels. Antimicrob. Agents Chemother. 30:951-952.
20. Sanders, W. E., J. H. Tenney, and R. E. Kessler. 1996. Efficacy of cefepime in the treatment of infections due to multiply resistant Enterobacter spp. Clin. Infect. Dis. 23:454-461.
21. Steward, C. D., J. K. Rasheed, S. K. Hubert, J. W. Biddle, P. M. Raney, G. J. Anderson, P. P. Williams, K. L. Brittain, A. Oliver, J. E. McGowan, Jr., and F. C. Tenover. 2001. Characterization of clinical isolates of Klebsiella pneumoniae from 19 laboratories using the National Committee for Clinical Laboratory Standards extended-spectrum beta-lactamase detection methods. J. Clin. Microbiol. 39:2864-2872.
22. Thomson, K. S. 2001. Controversies about extended-spectrum and AmpC beta-lactamases. Emerg. Infect. Dis. 7:333-336.